Search | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Displaying 3 results.

- Speech
Intensive chemotherapy versus autologous or allogeneic stemcell transplantation for the treatment of patients with poor risk MDS and secondary AML-A joint study of the Eortc, Ebmt, Hovon, Swiss, Scandinavian and Gimema leukemia groups: A biomed-2 EU-project.
deWitte, TM Ferrant, Augustin[UCL] Suciu, Stefan[UCL] Anak, O Hagemeijer, Anne[UCL] Selleslag, D. Delforge, Michel[UCL] Belhabi, A Schouten, H Gratwohl, A. Aul, C Aivado, M Amadori, S. Muus, P. Tigaud, I. Jotterand-Bellomo, M Willemze, R. (1999) —
- Journal article
The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)
Oosterveld, M Ferrant, Augustin[UCL] Suciu, Stefan[UCL] Verhoef, G. Labar, B. Belhabri, A Aul, C Selleslag, D. Wijermans, P Mandelli, F. Amadori, S. Jehn, U. Muus, P. Zittoun, R Hess, U. Anak, O Beeldens, F. Willemze, R. de Witte, T. (2003) Leukemia — Vol. 17, no. 5, p. 859-868 (2003)
- Journal article
Highlights and strategies of the EORTC Leukemia Group
de Witte, T. Marie, JP Suciu, Stefan[UCL] Anak, O (2002) European Journal of Cancer — Vol. 38, p. S94-S99 (2002)